REVOLVE and Recover™ Launch Sustainable Denim Collection With Lovers and Friends
Global fashion retailer REVOLVE has partnered with Recover™, leading producer in recycled cotton fiber, to introduce a sustainable denim collection with REVOLVE-owned brand Lovers and Friends.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211014005745/en/
(Photo: Business Wire)
Recover™ is an innovative textile fiber producer that has been pioneering sustainable materials and recycling since 1947. The company recycles post-industrial and post-consumer cotton waste, replacing the need to cultivate cotton, dramatically reducing water waste, limiting the use of dyes through its RColorBlend system, and reducing textile landfill waste.
Launched today, the range features 14 styles of jeans, each produced with a minimum of 15% Recover™ recycled cotton fiber made from post-consumer denim.
The pairing of the valuable resources Recover™ provides with Lovers and Friends underscores REVOLVE’s commitment to sustainable fashion, and leading the change towards a more circular, and enduring fashion system.
“REVOLVE has a responsibility to contribute positively to the longevity of our industry and ecosystem, and for us, this process begins at home. We have worked with thousands of brands and suppliers, and Recover™ is unparalleled in its expertise and long-term focus. We are proud to partner with this multigeneration, family-owned business to deliver the strongest messaging and product to our consumers with one of our most recognizable owned brands, Lovers and Friends.” - Michael Mente, Co-CEO and Co-Founder REVOLVE Group.
“It is great to launch this sustainable collection today with such an iconic American brand and denim product. By incorporating Recover´s lowest-impact, highest-quality recycled fiber into the Lovers and Friends denim line we have created a strong collaboration that is helping to bring sustainable fashion closer to the consumer. Recover™ aims to scale its recycled cotton fiber production to help more brands meet their sustainable goals and achieve circular fashion for all.” - Alfredo Ferre, CEO Recover™
Recover™ has already supplied its recycled cotton and cotton blend fibers to illustrious brands such as Wrangler, H&M Group, Tommy Hilfiger, G-Star, The North Face, Billabong and Primark among many others during its rich history.
“Recover™ is building a strong ingredient brand, with the mission to dramatically enhance the environmental value of the garment for the final customer. We’ve taken special care in the way we inform them about the impact of this collection in collaboration with REVOLVE. The hang tag includes a QR code that leads to more information about the environmental savings, such as water, and compares them to day-to-day activities, like the number of showers, to make them more understandable.” – Boris Mercier, Marketing Director Recover™
By adding REVOLVE and Lovers and Friends to its portfolio, Recover™ moves one step closer to achieving its mission of “circular fashion for all”.
Price Range: $128-$158. Available at REVOLVE.com
Recover™ is a leading material sciences company and global producer of low-impact, high-quality recycled cotton fiber and cotton fiber blends. Its premium, environmentally friendly, and cost-competitive products are created in partnership with the supply chain for global retailers and brands, offering a sustainable solution to achieve circular fashion for all.
As a fourth-generation, family-owned company with over a 70-year history in the textile industry, Recover™ is on a mission to scale its proprietary technology to make a lasting positive impact on the environment and partner with brands/retailers and other change-makers to meet the industry’s sustainability targets. Recover™was honored in Fast Company’s Innovation by Design Awards for 2021 in the Sustainability and Materials categories.
For more information, visit www.recoverfiber.com and follow @recoverfiber on social media.
REVOLVE is the next-generation fashion retailer for Millennial and Generation Z consumers. As a trusted, premium lifestyle brand and a go-to source for discovery and inspiration, REVOLVE delivers an engaging customer experience from a vast yet curated offering of over 45,000 products. Founded in Los Angeles in 2003 by co-CEOs, Michael Mente and Mike Karanikolas, REVOLVE’s family of brands includes their luxury offering, FWRD.com, and a portfolio of owned brands such as Lovers and Friends, Tularosa, NBD and RAYE. For more information, please visit www.revolve.com, or find us on Instagram, Twitter, Pinterest, and Facebook.
About Lovers and Friends
Inspired by the laid back Los Angeles lifestyle in which the brand was founded, Lovers and Friends exudes effortless style and wearability, creating a signature sexy-meets-chic look with a California-cool sensibility. Lovers and Friends is designed for the girl who is a go-getter and fun-seeker. Every trend-inspired outfit is perfectly curated for her event-filled social schedule, whether she's meeting her girls for brunch or jet-setting to another coast. Sometimes sassy, sometimes sweet but always chic - she is both a LOVER and a FRIEND.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Quantfury Introduces Fractional Trading Mode for Stocks, ETFs and Commodities28.11.2022 19:00:00 CET | Press release
Quantfury Trading Limited (“Quantfury”), a global brokerage firm that delivers commission-free trading and investing at real-time spot prices of global and crypto exchanges, today announced the launch of fractional trading mode with more than 1500+ stocks, ETFs and commodity futures contracts available to trade on the Quantfury platform. Quantfurians can now buy and sell fractional shares of all stocks, ETFs and commodity futures contracts at their real-time US and European exchanges spot prices with zero commissions and borrowing fees, providing improved trading and investment experience. “Quantfury is advancing its unmatched trading and investing conditions further by making it even more affordable to Quantfurians out there,” said Daniel Muvdi, Quantfury’s Head of Markets. “Fractional trading mode opens up more trading opportunities to the Quantfury global audience of more than 400,000 Quantfurians.” Fractional trading mode is available on all Quantfury trading platforms immediately,
The 4 th World Science and Technology Development Forum Held in Chengdu28.11.2022 17:06:00 CET | Press release
The 4th World Science and Technology Development Forum with the theme “Openness, Trust and Cooperation” kicked off in Chengdu on November 27, 2022, which was attended by more than 300 top experts and scholars, representatives of international organizations, and entrepreneurs, from more than 20 countries and regions, including 7 Nobel laureates and more than 60 academicians home and abroad. Together, they discussed technological innovation and sustainable development in key fields such as basic science, climate change, digital economy, and green innovation, and proposed technological innovation solutions to address the challenges of today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005539/en/ The 4th World Science and Technology Development Forum Held in Chengdu (Photo: Business Wire) The world today is facing many challenges, such as the COVID-19 pandemic, energy security, food security, climate change, poverty, an
Biocytogen Enters into Antibody Agreement with ADC Therapeutics28.11.2022 15:47:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today announced that it has entered into an evaluation and option agreement with ADC Therapeutics SA. Biocytogen will grant ADC Therapeutics a license to evaluate Biocytogen’s proprietary antibodies against three tumor targets, with an option to license selected antibodies at a later date for global ADC development and commercialization. Biocytogen reserves all global rights for these antibodies beyond ADC development. Biocytogen will receive an upfront payment. For each option exercised, Biocytogen will be entitled to an option-exercise fee, and development and commercial milestone payments, which potentially total tens of millions of US dollars, as well as single-digit royalties on net sales. Under the agreement, Biocytogen will provide ADC Therapeutics with monoclonal and/or biparatopic antibodies directed against three tumor targets, generated through Biocytogen’s Project Integrum (also called RenMiceTM HiTS
Medimaps Group Appoints Meinhard F. Schmidt as Board Chairman; Adds Anne Le Grand and Five Additional Board Members28.11.2022 15:15:00 CET | Press release
Medimaps Group (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced new appointments to its Board of Directors, effective immediately. Meinhard F. Schmidt, an international MedTech/BioTech and Digital Health executive with 25+ years of experience, has been named Board Chairman; and Anne Le Grand,an accomplished healthcare executive and consultant with 30+ years in the global healthcare technology industry, has joined as an independent board member. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005146/en/ Medimaps Group Announces Board Members: Meinhard F. Schmidt as Board Chairman, and Anne Le Grand Plus Five Other Members and One Strategic Advisor. (Photo: Business Wire) Five additional board members and one board advisor have also been named, bolstering Medimaps investment and clinical policy expertise. Visit Medimaps website fo
Viz.ai Appoints Radiology Advisory Board to Advance Innovation28.11.2022 14:00:00 CET | Press release
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the creation of its Radiology Advisory Board to assist Viz.ai in the development of strategy and products to support radiologists and patients. The Board consists of 14 leading healthcare experts with diverse experience and roles in radiology. “I am honored to co-chair the Radiology Advisory Board and excited about Viz.ai’s commitment to customers and patients to invest in innovation that increases access to life-saving therapies,” said Kevin Abrams, MD, medical director of neuroradiology and MRI and chief of radiology at Baptist Hospital in Miami. “I am looking forward to the rich dialogue to be discussed in our inaugural meeting, exploring future ideas.” “I’m looking forward to working with these esteemed board members to help shape Viz.ai’s Radiology Program through patient-centric vision, passion, and insights,” said Suzie Bash, MD, Co-Chair of the Viz.ai Radiology Advisory Board a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom